Steven O’Day
Technik-/Wissenschafts-/F&E-Leiter bei AGENUS INC.
Vermögen: 213 682 $ am 31.05.2024
Profil
Steven O’Day currently works at Agenus, Inc., as Chief Medical Officer from 2021.
Dr. O’Day also formerly worked at John Wayne Cancer Institute, as Executive Director.
Dr. O’Day received his undergraduate degree from Williams College and doctorate degree from The Johns Hopkins University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AGENUS INC.
0,06% | 11.06.2024 | 13 619 ( 0,06% ) | 213 682 $ | 31.05.2024 |
Aktive Positionen von Steven O’Day
| Unternehmen | Position | Beginn |
|---|---|---|
| AGENUS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ehemalige bekannte Positionen von Steven O’Day
| Unternehmen | Position | Ende |
|---|---|---|
John Wayne Cancer Institute
 John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | Direktor/Vorstandsmitglied | - |
Ausbildung von Steven O’Day
| Williams College | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AGENUS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
John Wayne Cancer Institute
John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | Commercial Services |
